AUSTIN, Texas--(BUSINESS WIRE)--Pattern Bioscience, Inc., an innovator in rapid diagnosis and antibiotic susceptibility testing for bacterial infections, today announced the appointments of Tim Skansi ...
Pattern Bioscience Inc. reeled in $28.7 million in a series C financing led by Illumina Ventures and Omnimed Capital. The money will be used to complete development of its rapid phenotypic test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results